Ispire posts yearly sales surge despite US cannabis woes
The firm’s losses widened off higher costs and a cannabis cash crunch, even as it seeks a FDA nod for a nicotine vapes return.
The post Ispire posts yearly sales surge despite US cannabis woes appeared first on Green Market Report.
